There is a rapidly expanding, virtually unregulated competitor to medical cannabis in Maryland. It’s called Delta-8

May 14, 2022

There is a rapidly expanding, virtually unregulated competitor to medical cannabis in Maryland. It’s called Delta-8.


“As the state’s medical cannabis regulator, we receive a lot of calls, emails, other correspondence from patients and parents concerned about what they think are medical cannabis products,” Tilburg said. “In actuality, they end up being Delta-8 THC products. … They are untested, unregulated and it’s unknown largely what is within them.”

 

He said a Maryland woman ended up hospitalized because of Delta-8. The woman later took the product to an independent lab, which said it contained copper, a potentially fatal metal that shuts down the liver, Tilburg said.

 

The CDC issued a health alert in September about Delta-8, saying there were 660 adverse events related to Delta-8 reported from January through July 2021, including 119 hospitalizations. Nearly 40% of the adverse events involved people under 18.



Read More via Baltimore Sun


Share This Story, Choose Your Platform!

Recent Articles

02 Jan, 2024
President Biden has expanded cannabi s pardons with a new proclamation covering offenses on federal property. 
02 Jan, 2024
Under the Cannabis Reform Act, counties have broad flexibility in determining how to allocate the funds, including working with local organizations to support marginalized communities.
02 Jan, 2024
The Office of Social Equity has issu ed the Community Reinvestment and Repair Fund Survey Results Report on how communities want to see cannabis tax revenue allocated.
Share by: